200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 566939-85-3
CAS No: 566939-85-3 Catalog No: AG00ECEF MDL No:
Title | Journal |
---|---|
Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC). | BMC urology 20140101 |
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. | The Journal of steroid biochemistry and molecular biology 20120401 |
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer. | Bioorganic & medicinal chemistry 20111101 |
CYP17 inhibitors for prostate cancer therapy. | The Journal of steroid biochemistry and molecular biology 20110501 |
© 2019 Angene International Limited. All rights Reserved.